The palladium catalyzed asymmetric allylic sulfonylation reaction has been investigated employing beta-hydroxy- and beta-(o-diphenylphosphino)benzoyloxy (o-diphenyl phosphino)benzamides as chiral non-racemic ligands The bisphosphine beta-benzoyloxybenzamide ligands proved to be the best ligands for this process Competitive transition states for the (1S 2R)-norephedrine derived ligand 14 are compared and a rationale is provided for the observed enantioselectivities (C) 2010 Elsevier Ltd All rights reserved
The palladium catalyzed asymmetric allylic sulfonylation reaction has been investigated employing beta-hydroxy- and beta-(o-diphenylphosphino)benzoyloxy (o-diphenyl phosphino)benzamides as chiral non-racemic ligands The bisphosphine beta-benzoyloxybenzamide ligands proved to be the best ligands for this process Competitive transition states for the (1S 2R)-norephedrine derived ligand 14 are compared and a rationale is provided for the observed enantioselectivities (C) 2010 Elsevier Ltd All rights reserved
The palladium catalyzed asymmetric allylic sulfonylation reaction has been investigated employing beta-hydroxy- and beta-(o-diphenylphosphino)benzoyloxy (o-diphenyl phosphino)benzamides as chiral non-racemic ligands The bisphosphine beta-benzoyloxybenzamide ligands proved to be the best ligands for this process Competitive transition states for the (1S 2R)-norephedrine derived ligand 14 are compared and a rationale is provided for the observed enantioselectivities (C) 2010 Elsevier Ltd All rights reserved